Zhejiang Chiral Medicine Chemicals Co.,Ltd.
Welcome to the website!

此頁面上的內容需要較新版本的 Adobe Flash Player。

獲取 Adobe Flash Player

API Introduction


Founded in 1998, Zhejiang Chiral Medicine Chemicals Co., Ltd (CMC) is located at Zhejiang Nanyang Economic Development Zone and occupies an area of 15,000m2.The company, specializing in generic APIs and pharmaceutical intermediates, has been accredited as a high-tech enterprise by Zhejiang Province.

QA, QC and R&D departments were set up along with the company in 1999, and are staffed with highly trained professionals, including some M.S and Ph.D. scientists. With powerful developing and manufacturing capabilities,CMC strives to meet the requirements of our customers with the highest quality products with innovative technologies. We are particularly specialized in synthesizing chiral pharmaceutical products, which is also the main direction of the company. During the past few years recent years, CMC developed a series of products and manufactured them following the GMP procedure, including Methyldopa , Gabapentin , Etodolac .

At present, there are about 200 employees in the company, with 20% of them being R&D staff. The company has achieved excellence in analysis, research and development. It is our aim to expand our product lines with the highest quality to customers around the globe.

In 2008, CMC have registered successfully in Canada for Gabapentin and Etodolac. In 2009, CMC obtained Gabapentin GMP certificate from SFDA and TGA certificate from Australia government. In 2010, CMC got new CEP certificate for Carbidopa from EDQM and approved by EDQM inspection. In January 2011, CMC got new CEP certificate for methyldopa and Etodolac from EDQM. In August of 2011, US FDA inspected us for Gabapentin and approved us,CMC received the acceptance letter and EIR report. In July of 2012, Germany Hamburg Authority inspected us and approved us, we got Gabapentin Germany EU GMP. During Jan.25-29th,2013, US FDA inspected our site, we got FDA approval for all the products (Gabapentin, Carbidopa, Etodolac, Methyldopa). In 2013, We got Etodolac GMP certificate from SFDA. In 2016, we got Carbidopa GMP certificate from SFDA. US FDA inspected our site again on Aug.9-11 2016, and we got FDA approval for all the products (Gabapentin, Carbidopa, Etodolac, Methyldopa). On Mar.28,2017, we received FDA close letter.

In 2016, Zhejiang Yongtai Technology Co.,Ltd. (Stock code:002326) acquired Zhejiang Chiral Medicine Chemicals Co.,Ltd. now Zhejiang Chiral is a wholly-owned subsidiary company of Zhejiang Yongtai. With support from Zhejiang Yongtai & its Platform of being a Public Company, Zhejiang Chiral is further improving its management system, operation levels and its core competiveness.


About us | Products | Honor | Equipment | Message | Contact us
Tel: +86-571-86657369 ?E-mail:[email protected] 浙ICP備05016172號-1
七乐彩走势图500期大 足彩进球彩 浙江十一选五 辽源凌龙棋牌官网 三式投注什么意思 福建快3 澳客彩票下载 上海时时平台 河北快三最稳定 河北时时在线投注 全民欢乐捕鱼赢话费 雪缘园即时比分园 天天捕鱼达人修改器 迅盈网球比分 北京pk赛车139开奖历史 安徽11选5专家推荐 手机足球比分网即时比分